DSM completes acquisition of stake in Andre Pectin (China)
(Thomson Reuters ONE) -
Royal DSM, the global Life Sciences and Materials Sciences company, announced
today that it has completed the acquisition of a 19% equity interest in Yantai
Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing
ingredients. DSM announced this acquisition on 5 May 2013.
DSM had previously acquired a 10% stake in Andre Pectin from Hony Capital. DSM's
total interest in Andre Pectin is now 29%. The parties have agreed that DSM has
option rights to increase its stake in Andre Pectin to a majority stake at a
later stage.
Andre Pectin, headquartered in Yantai (Shandong Province, China), was
established in 2003 and is active in the manufacturing and sale of apple and
citrus pectin, a key food hydrocolloid providing texture, as well as pectin
related food products. Andre Pectin realizes annual net sales of around ?30
million. As the only successful global pectin market entrant in the past 20
years, Andre Pectin is the only significant pectin manufacturer in Asia with
premier access to the world's fastest growing specialty food ingredients market.
With a market size of around ?6 billion with an annual average growth rate of
3-5%, the global hydrocolloids market provides an attractive growth area to
leverage DSM's bio-ingredients capabilities and global customer access. Some
food hydrocolloids, such as pectin and gellan gum possess unique properties that
are highly relevant to a broad range of processed and healthy food applications.
DSM's investment in Andre Pectin, synergistically combined with the previously
acquired gellan gum assets based in China, creates a China-based hydrocolloids
growth platform, in line with DSM's strategy for the Nutrition cluster,
Continued Value Growth.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around ?9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.
Or find us on:
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1734440/580927.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1734440]
Unternehmensinformation / Kurzprofil:
Datum: 09.10.2013 - 08:15 Uhr
Sprache: Deutsch
News-ID 304129
Anzahl Zeichen: 3723
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM completes acquisition of stake in Andre Pectin (China)"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
